Synthesis, Computational Studies and Preliminary Pharmacological Evaluation of New Arylpiperazines
Author(s) -
Sushil Kumar,
A. K. Wahi,
Ranjit Singh
Publication year - 2010
Publication title -
journal of chemistry
Language(s) - English
Resource type - Journals
eISSN - 2090-9063
pISSN - 2090-9071
DOI - 10.1155/2011/346087
Subject(s) - antagonism , catalepsy , apomorphine , pharmacology , clozapine , antipsychotic , chemistry , risperidone , stereochemistry , atypical antipsychotic , biochemistry , haloperidol , psychology , biology , medicine , dopamine , receptor , psychiatry , agonist , schizophrenia (object oriented programming)
A series of novel arylpiperazines were synthesized and the target compounds evaluated for atypical antipsychotic activity in apomorphine induced climbing behavior (D2 antagonism), 5-HTP induced head twitches (5-HT2A antagonism) and catalepsy studies in albino mice. The physicochemical similarity of the target compounds with respect to standard drugs clozapine, ketanserine and risperidone was assessed by calculating from a set of physiochemical properties using software programs. The test compounds (3a-j) demonstrated good similarity values with respect to the standard drugs. Among them, compound 3d has emerged as an important lead compound showing potential atypical antipsychotic like profile.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom